Muscular myostatin gene expression and plasma concentrations are decreased in critically ill patients
Abstract Background The objective was to investigate the role of gene expression and plasma levels of the muscular protein myostatin in intensive care unit-acquired weakness (ICUAW). This was performed to evaluate a potential clinical and/or pathophysiological rationale of therapeutic myostatin inhi...
Main Authors: | Julius J. Grunow, Katja Reiher, Niklas M. Carbon, Lilian Jo Engelhardt, Knut Mai, Susanne Koch, Joerg C. Schefold, Werner Z’Graggen, Stefan J. Schaller, Jens Fielitz, Joachim Spranger, Steffen Weber-Carstens, Tobias Wollersheim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-022-04101-1 |
Similar Items
-
Sex-Specific Aspects of Skeletal Muscle Metabolism in the Clinical Context of Intensive Care Unit-Acquired Weakness
by: Lilian Jo Engelhardt, et al.
Published: (2022-02-01) -
Serum amyloid A1 mediates myotube atrophy via Toll‐like receptors
by: Alexander Hahn, et al.
Published: (2020-02-01) -
The elusive role of myostatin signaling for muscle regeneration and maintenance of muscle and bone homeostasis
by: Akash Mitra, et al.
Published: (2023-03-01) -
A novel splice variant of the human MSTN gene encodes a myostatin‐specific myostatin inhibitor
by: Kazuhiro Maeta, et al.
Published: (2023-10-01) -
Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
by: Yukun Liu, et al.
Published: (2023-07-01)